What is she best known for?
The fields of study she is best known for:
Genetic enhancement, Immunology, Severe combined immunodeficiency, Molecular biology and Cell biology are her primary areas of study.
Her Genetic enhancement research integrates issues from Insertional mutagenesis, Vector, Viral vector and In vivo.
Her Immunology research includes elements of HAX1 and G6PC3.
Her Severe combined immunodeficiency research is multidisciplinary, incorporating perspectives in Progenitor cell, Stem cell, Natural killer cell and Transplantation.
Christine Kinnon combines subjects such as Gene expression, Gene, Receptor tyrosine kinase and Bruton's tyrosine kinase with her study of Molecular biology.
As a part of the same scientific study, Christine Kinnon usually deals with the Gene, concentrating on Kinase and frequently concerns with Locus and X-linked agammaglobulinemia.
Her most cited work include:
- The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases (1181 citations)
- Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients (912 citations)
- Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector (603 citations)
What are the main themes of her work throughout her whole career to date?
Christine Kinnon spends much of her time researching Immunology, Genetic enhancement, Genetics, Molecular biology and Gene.
Her Immunology research incorporates elements of Mutation, Severe combined immunodeficiency and Transplantation.
Her study in Severe combined immunodeficiency is interdisciplinary in nature, drawing from both Progenitor cell and Natural killer cell.
Her studies deal with areas such as Cancer research, Viral vector, Transgene and Virology as well as Genetic enhancement.
Her Virology study combines topics in areas such as Cytotoxic T cell, Haematopoiesis, Adeno-associated virus and Disease.
Her studies in Molecular biology integrate themes in fields like IL-2 receptor, Chronic granulomatous disease, Transfection, B cell and Reporter gene.
She most often published in these fields:
- Immunology (38.71%)
- Genetic enhancement (28.11%)
- Genetics (23.50%)
What were the highlights of her more recent work (between 2006-2018)?
- Genetic enhancement (28.11%)
- Immunology (38.71%)
- World Wide Web (10.60%)
In recent papers she was focusing on the following fields of study:
Her scientific interests lie mostly in Genetic enhancement, Immunology, World Wide Web, Severe combined immunodeficiency and Cell biology.
The various areas that she examines in her Genetic enhancement study include Cancer research, Clinical trial, Bioinformatics, Viral vector and Hematopoietic stem cell.
Her research integrates issues of Molecular biology, Transgene and In vivo in her study of Viral vector.
Her Immunology study combines topics from a wide range of disciplines, such as Progenitor cell, Haematopoiesis, Stem cell and Transplantation.
Her study in Severe combined immunodeficiency focuses on X-linked severe combined immunodeficiency in particular.
Her work in Cellular immunity addresses issues such as Virology, which are connected to fields such as Gene.
Between 2006 and 2018, her most popular works were:
- Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients (912 citations)
- Hematopoietic Stem Cell Gene Therapy for Adenosine Deaminase–Deficient Severe Combined Immunodeficiency Leads to Long-Term Immunological Recovery and Metabolic Correction (214 citations)
- Gammaretrovirus-mediated correction of SCID-X1 is associated with skewed vector integration site distribution in vivo (185 citations)
In her most recent research, the most cited papers focused on:
Her primary areas of investigation include Genetic enhancement, Immunology, Severe combined immunodeficiency, Molecular biology and Viral vector.
Her Genetic enhancement research includes themes of Cancer research, In vivo and Virology.
The study incorporates disciplines such as Cytotoxic T cell and Hematopoietic stem cell in addition to Immunology.
Her Severe combined immunodeficiency study integrates concerns from other disciplines, such as Progenitor cell and Transplantation.
Her biological study spans a wide range of topics, including Gene expression, Transduction, Cell biology, Spindle midzone and Arp2/3 complex.
Regulation of gene expression, Reporter gene, Myeloid and CAAT box is closely connected to Transgene in her research, which is encompassed under the umbrella topic of Viral vector.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
